Professor of Neonatal Medicine, University of Bristol
Karen Luyt read medicine in South Africa and specialised in Paediatrics (Neonatal Medicine) in the UK. She has a clinical academic post, based in Neonatal Intensive Care at St Michael’s Hospital and the University of Bristol.
Karen’s laboratory-based research focuses on mechanisms of injury and protection and in the newborn brain. Her clinical research concerns neuroprotection and optimising health outcomes in newborn infants.
Karen is the clinical lead for the National PReCePT (Prevention of Cerebral Palsy in Preterm Birth) QI Programme and Health Foundation funded PReCePT-Study, focused on optimising the uptake of Magnesium Sulphate for fetal brain protection, in every unit in England. She is strategic clinical lead for PERIPrem (Perinatal Excellence to Reduce Injury in Premature Birth) and programme lead for the National Child Mortality Database (NCMD). These roles have the aligned purpose to improve survival and reduce brain injury for the most vulnerable infants.
Twitter: @KarenLuyt @PReCePT_MgSO4 @peri_prem @NCMD_England